Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2425554rdf:typepubmed:Citationlld:pubmed
pubmed-article:2425554lifeskim:mentionsumls-concept:C0815000lld:lifeskim
pubmed-article:2425554lifeskim:mentionsumls-concept:C0036442lld:lifeskim
pubmed-article:2425554lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:2425554pubmed:issue1lld:pubmed
pubmed-article:2425554pubmed:dateCreated1986-8-8lld:pubmed
pubmed-article:2425554pubmed:abstractTextMembrane effects of scopolamine on N1E-115 neuroblastoma cells were studied using intracellular recording techniques. Scopolamine in concentrations of 50 nM-1 microM induced a depolarization together with a decreased cell input resistance. This response had a reversal potential at +10 to +20 mV in a medium with normal sodium concentration (146.5 mM), and a reversal potential around -10 mV when the sodium concentration in the medium was lowered to 80 mM. The scopolamine-induced depolarization could not be blocked by carbachol (100 microM), and had a reversal potential at +10 to +20 mV. The simplest explanation of the results obtained is that scopolamine increases the membrane permeability for sodium and potassium, in a manner which is not related to muscarinic cholinergic receptors.lld:pubmed
pubmed-article:2425554pubmed:languageenglld:pubmed
pubmed-article:2425554pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2425554pubmed:citationSubsetIMlld:pubmed
pubmed-article:2425554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2425554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2425554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2425554pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2425554pubmed:statusMEDLINElld:pubmed
pubmed-article:2425554pubmed:monthMaylld:pubmed
pubmed-article:2425554pubmed:issn0001-6772lld:pubmed
pubmed-article:2425554pubmed:authorpubmed-author:SydbomAAlld:pubmed
pubmed-article:2425554pubmed:authorpubmed-author:ArhemPPlld:pubmed
pubmed-article:2425554pubmed:authorpubmed-author:HedlundBBlld:pubmed
pubmed-article:2425554pubmed:authorpubmed-author:LorentzMMlld:pubmed
pubmed-article:2425554pubmed:issnTypePrintlld:pubmed
pubmed-article:2425554pubmed:volume127lld:pubmed
pubmed-article:2425554pubmed:ownerNLMlld:pubmed
pubmed-article:2425554pubmed:authorsCompleteYlld:pubmed
pubmed-article:2425554pubmed:pagination127-32lld:pubmed
pubmed-article:2425554pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:meshHeadingpubmed-meshheading:2425554-...lld:pubmed
pubmed-article:2425554pubmed:year1986lld:pubmed
pubmed-article:2425554pubmed:articleTitleNon-muscarinic effects of scopolamine on N1E-115 neuroblastoma cells.lld:pubmed
pubmed-article:2425554pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2425554pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2425554lld:pubmed